Logo image
Genetic, Immunologic, and Environmental Basis of Sarcoidosis
Journal article   Open access   Peer reviewed

Genetic, Immunologic, and Environmental Basis of Sarcoidosis

David R Moller, Ben A Rybicki, Nabeel Y Hamzeh, Courtney G Montgomery, Edward S Chen, Wonder Drake and Andrew P Fontenot
Annals of the American Thoracic Society, Vol.14(Supplement_6), pp.S429-S436
12/2017
DOI: 10.1513/AnnalsATS.201707-565OT
PMCID: PMC5822412
PMID: 29073364
url
https://doi.org/10.1513/AnnalsATS.201707-565OTView
Published (Version of record) Open Access

Abstract

Sarcoidosis is a multisystem disease with tremendous heterogeneity in disease manifestations, severity, and clinical course that varies among different ethnic and racial groups. To better understand this disease and to improve the outcomes of patients, a National Heart, Lung, and Blood Institute workshop was convened to assess the current state of knowledge, gaps, and research needs across the clinical, genetic, environmental, and immunologic arenas. We also explored to what extent the interplay of the genetic, environmental, and immunologic factors could explain the different phenotypes and outcomes of patients with sarcoidosis, including the chronic phenotypes that have the greatest healthcare burden. The potential use of current genetic, epigenetic, and immunologic tools along with study approaches that integrate environmental exposures and precise clinical phenotyping were also explored. Finally, we made expert panel-based consensus recommendations for research approaches and priorities to improve our understanding of the effect of these factors on the health outcomes in sarcoidosis.
Environmental Exposure - adverse effects Phenotype National Heart, Lung, and Blood Institute (U.S.) United States Humans Risk Factors Sarcoidosis - immunology Sarcoidosis - genetics Biomedical Research - trends Consensus

Details

Metrics

Logo image